Can a Weight-Loss drug slow prostate cancer? a trial investigates
NCT ID NCT07727473
First seen Jul 27, 2026 · Last updated Jul 27, 2026
Summary
This trial explores whether semaglutide, a drug approved for weight management, can affect tumor biology when given for 3 to 6 months before prostate removal surgery. About 20 men with intermediate-risk localized prostate cancer and a BMI over 35 will receive weekly injections. Researchers will measure changes in tumor cell activity and cancer markers in tissue samples taken before and after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide, a GLP-1 receptor agonist drug used for weight management
- What this could lead to
- If semaglutide shows anti-tumor activity, it could point toward a new treatment approach for prostate cancer that also improves metabolic health.
- What could go wrong
- This is a very early, small trial with only 20 participants and no comparison group. The drug is being tested for its effect on tumor markers, not for curing cancer, and may cause side effects like nausea or gastrointestinal issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERMEDIATE-RISK LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner MD Anderson Cancer Center at Gateway
Gilbert, Arizona, 85234, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A cool wristband takes on hot flashes — no drugs needed
- Tailored breathing support may protect lungs during robot prostate surgery
- A surgical tweak may speed bladder control recovery after prostate removal
- Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies
- Glow-in-the-dark dye may help surgeons spot hidden prostate cancer cells
- Blood DNA fragments and MRI join forces to spot hidden prostate cancer